Request Demo
Recent blog posts
Latest Hotspot
8 min read
ADGRG1 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor G1 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ADGRG1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
ADGRE5 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor E5 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ADGRE5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
ADGRF4 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor F4 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ADGRF4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
ADGRE2 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor E2 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ADGRE2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
ADGRE1 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor E1 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ADGRE1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
ADGRE3 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor E3 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ADGRE3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
ADGRD1 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor D1 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of ADGRD1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
TRADD Biologics Sequence Review Report 2026: Tumor necrosis factor receptor type 1-associated DEATH domain protein Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of TRADD protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
CCL4L1; Biologics Sequence Review Report 2026: C-C motif chemokine 4-like Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CCL4L1; protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
XCR1 Biologics Sequence Review Report 2026: Chemokine XC receptor 1 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of XCR1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
CCL3L1; Biologics Sequence Review Report 2026: C-C motif chemokine 3-like 1 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of CCL3L1; protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
SELPLG Biologics Sequence Review Report 2026: P-selectin glycoprotein ligand 1 Similarity and Patent-Risk Signals
14 August 2026
A Biology Modality MCP review of SELPLG protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.